Earnings dates and session timing shown here are aggregated from third-party sources, are frequently estimated, and are subject to change or confirmation by the reporting company. Nothing on this site is financial advice.
Perspective Therapeutics Inc. (CATX) is a pioneering biotechnology firm focused on revolutionizing cancer care through the development of innovative radiopharmaceuticals. Leveraging state-of-the-art radioisotope technologies, CATX seeks to enhance the precision and effectiveness of cancer therapies, aiming to significantly improve patient survival rates across various malignancies. Backed by a seasoned leadership team and strong strategic alliances, the company is strategically positioned to drive advancements in targeted cancer treatments, addressing significant healthcare challenges in a competitive landscape.
Quotes and fundamental data are delayed and provided for informational purposes only — nothing on this page is financial advice. Figures are as reported by the company and its data providers and may be revised. Estimates reflect analyst consensus at the time of each report.
$3.13
| Quarter | EPS | Revenue | Price move | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Est | Adj | Result | GAAP | Est | Actual | Surprise | 1D Pre | On-Day | 1D Post | |
Q ended Jun 30, 2026 Reported Aug 10, 2026 | $-0.27 | $-0.22 | Beat +18.5% | $-0.22 | $92.5K | $81.0K | -12.4% | 1D Pre+1.0% | On-Day0.0% | 1D Post+6.0% |
Q ended Mar 31, 2026 Reported May 11, 2026 | $-0.32 | $-0.25 | Beat +21.9% | — | $137.2K | $76.0K | -44.6% | 1D Pre+4.4% | On-Day+3.2% | 1D Post-2.8% |
Q ended Dec 31, 2025 Reported Mar 16, 2026 | $-0.35 | $-0.50 | ||||||||
Dashed outlines show the analyst consensus estimate for periods where one was published. Hover or tap a bar for exact figures. Values as reported; not adjusted for splits after the report date.
| Miss -42.9% |
| — |
| $237.0K |
| $43.0K |
| -81.9% |
| 1D Pre-2.2% |
| On-Day+4.4% |
| 1D Post-5.2% |
Q ended Sep 30, 2025 Reported Nov 10, 2025 | $-0.32 | $-0.35 | Miss -9.4% | — | $206.8K | $209.0K | +1.1% | 1D Pre-1.8% | On-Day+1.4% | 1D Post0.0% |